Details of the Drug Formulations

General Information of Drug (ID: DMH6IKO)

• Drug Name: Lusutrombopag Drug Info
• Synonyms: LUSUTROMBOPAG; mulpleta; UNII-6LL5JFU42F; 6LL5JFU42F; 2-Propenoic acid, Lusutrombopag [USAN:INN]; SCHEMBL3062

Indication

Disease Entry	ICD 11	Status	REF
Thrombocytopenia	3B64	Approved	[1]
Liver disease	DB90-BD99	Phase 2	[2]

• Cross-matching ID:
  PubChem CID: 49843517
  ChEBI ID: CHEBI:136051
  CAS Number: 1110766-97-6
  TTD ID: D0TD1R
  ACDINA ID: D01232

Full List of Drug Formulations Containing This Drug

Lusutrombopag 3 mg tablet

Company	Formulation ID	FDA Description
Shionogi	F23221	D-Mannitol; Microcrystalline Cellulose; Magnesium Oxide; Sodium Lauryl Sulfate; Hydroxypropyl Cellulose; Carboxymethylcellulose Calcium; Magnesium Stearate; Hypromellose; Triethyl Citrate; Titanium Dioxide; Red Ferric Oxide; Talc

References

• [1] 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.
• [2] ClinicalTrials.gov (NCT01054443) A Study to Investigate the Efficacy and Safety of S-888711 Tablets Administered to Adult Subjects With Immune Thrombocytopenia (ITP). U.S. National Institutes of Health.